AstraZeneca | F-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
AstraZeneca | 8-A12B: Registration of a class of securities on a national securities exchange
AstraZeneca | 424B2: Prospectus
AstraZeneca | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
AstraZeneca | 424B2: Prospectus
AstraZeneca | 144: Notice of Proposed Sale of Securities
AstraZeneca | 8-A12B: Registration of a class of securities on a national securities exchange
AstraZeneca | 424B2: Prospectus
AstraZeneca | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
AstraZeneca | 424B2: Prospectus
AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
AstraZeneca | 8-A12B: Registration of a class of securities on a national securities exchange
AstraZeneca | 424B2: Prospectus
AstraZeneca | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
No Data